ProVise Management Group’s Apyx Medical APYX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$30.4K	Hold	13,499	–	–	﹤0.01%	259
2025 Q1	$18.5K	Hold	13,499	–	–	﹤0.01%	249
2024 Q4	$21.3K	Hold	13,499	–	–	﹤0.01%	258
2024 Q3	$16.7K	Hold	13,499	–	–	﹤0.01%	296
2024 Q2	$18.1K	Hold	13,499	–	–	﹤0.01%	295
2024 Q1	$18.4K	Hold	13,499	–	–	﹤0.01%	298
2023 Q4	$35.4K	Buy	+13,499	New	+$35.4K	﹤0.01%	342
2023 Q2	–	Sell	-13,499	Closed	-$38.9K	–	345
2023 Q1	$38.9K	Hold	13,499	–	–	﹤0.01%	341
2022 Q4	$31.6K	Buy	+13,499	New	+$31.6K	﹤0.01%	317
2022 Q1	–	Sell	-111,189	Closed	-$1.43M	–	374
2021 Q4	$1.43M	Hold	111,189	–	–	0.13%	148
2021 Q3	$1.54M	Buy	111,189 +3,499	+3%	+$48.5K	0.15%	142
2021 Q2	$1.11M	Hold	107,690	–	–	0.11%	161
2021 Q1	$1.04M	Hold	107,690	–	–	0.11%	158
2020 Q4	$775K	Sell	107,690 -46,100	-30%	-$332K	0.09%	179
2020 Q3	$724K	Sell	153,790 -17,000	-10%	-$80K	0.1%	172
2020 Q2	$948K	Sell	170,790 -4,000	-2%	-$22.2K	0.14%	137
2020 Q1	$627K	Hold	174,790	–	–	0.11%	156
2019 Q4	$1.48M	Sell	174,790 -12,560	-7%	-$106K	0.18%	124
2019 Q3	$1.27M	Sell	187,350 -60,000	-24%	-$406K	0.17%	130
2019 Q2	$1.66M	Sell	247,350 -50,000	-17%	-$336K	0.22%	116
2019 Q1	$1.88M	Sell	297,350 -12,460	-4%	-$78.6K	0.26%	102
2018 Q4	$2.01M	Hold	309,810	–	–	0.32%	86
2018 Q3	$2.2M	Sell	309,810 -21,100	-6%	-$150K	0.29%	101
2018 Q2	$1.44K	Buy	+330,910	New	+$1.44K	0.11%	142